Bioperfectus sets out for post-pandemic daily surveillance: COVID-19 Antigen Rapid Test included in the EU Common List

Home    Company news    Bioperfectus sets out for post-pandemic daily surveillance: COVID-19 Antigen Rapid Test included in the EU Common List
2021-07-19 14:51
Views:0

We Bioperfectus are glad to announce that our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit has been included in the EU Health Security Committee common list of COVID-19 rapid antigen tests.

 

The detection capacity of Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit for the SARS-CoV-2 mutation lineages (B.1.1.7, B.1.351, B.1.617.1 and P.1) has also been validated. Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit can detect SARS-CoV-2 within 15 minutes and compatible with specimens of nasal swab, nasopharyngeal swab and oropharyngeal swab. With package of 1, 2, 5, 10, 15, 20, 25, 50 Tests/Kit, our kits provide flexible options to fulfill different clinical throughput requirements.